Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy-Reference-Cited by-同舟云学术

Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy

Published:2004-10-08 Issue:6 Volume:15 Page:1174-1181
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Patri Anil K.¹,Myc Andrzej¹,Beals James¹,Thomas Thommey P.¹,Bander Neil H.¹,Baker James R.¹

Affiliation:

1. Center for Biologic Nanotechnology, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, Michigan 48109, and Department of Urology, New York Presbyterian Hospital-Weill Medical College of Cornell University, 525 E. 68th Street, New York, New York 10021

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc0499127

Reference30 articles.

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer;Cancer Epigenetics and Nanomedicine;2024

2. Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview;Pharmaceutics;2023-05-04

3. Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy;Journal of Drug Delivery Science and Technology;2023-03

4. Role of Nanotechnology‐Based Materials in Drug Delivery;Advances in Novel Formulations for Drug Delivery;2023-02-07

5. Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases;Pharmaceutics;2022-09-08